Nishadil
Signup Signin
Delhi | 25°C (windy)
The Unseen Hurdles: Intellia's Gene-Editing Dream Hits a Safety Snag

The Unseen Hurdles: Intellia's Gene-Editing Dream Hits a Safety Snag
The CRISPR Horizon: Intellia's Bold Leap Into Our Genetic Future, One Edit at a Time

The CRISPR Horizon: Intellia's Bold Leap Into Our Genetic Future, One Edit at a Time
BioCryst Pharmaceuticals Strikes Strategic $700 Million Deal, Propelling Astria's HAE Pipeline and Strengthening Its Own Focus

BioCryst Pharmaceuticals Strikes Strategic $700 Million Deal, Propelling Astria's HAE Pipeline and Strengthening Its Own Focus
KalVista's Game-Changing HAE Drug Gets Green Light in EU & Switzerland, Stock Set to Explode!

KalVista's Game-Changing HAE Drug Gets Green Light in EU & Switzerland, Stock Set to Explode!
European Triumph: KalVista and Ionis Celebrate Key Drug Approvals Across the EU

European Triumph: KalVista and Ionis Celebrate Key Drug Approvals Across the EU
Load more..